Lonza EasyDiff supplements for bone marrow CD34+
Primary human bone marrow hematopoietic progenitors are multipotent cells that can differentiate into several lineages. EasyDiff supplements allow differentiation of CD34+ cells into three different hematopoietic lineages (myeloid, erythroid and megakaryocytic) in 96-well plates.
Users simply add the appropriate volume of media (LGM-3 or IMDM) to dilute the supplement and mix with CD34+ cells in media. Once plated into 96-well plates differentiation will be complete in 10-12 days.
There is no need for methylcellulose or any substrate. Users can verify differentiation via quantification of the expression of lineage-specific markers.
The supplements are suitable for both drug discovery and toxicology research.
Phone: 1300 657508
Biosensis MAP2 antibodies
Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...
Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration
The antibodies are specific to CTC surface markers to enable the sensitive and specific...
Microbiologics UV-BioTAG QC microorganisms for quality control testing
UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...
Learn More
I am interested in Lonza EasyDiff supplements for bone marrow CD34+.
Complete the form and a supplier representative will be in touch.
